WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.26) by 11.54 percent. This is a 20.83 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $9.18 million which missed the analyst consensus estimate of $12.23 million by 24.96 percent. This is a 26.82 percent decrease over sales of $12.54 million the same period last year.